NextCure, Inc. Stock: price and insider trades · United States

This page follows insider dealings at NextCure, Inc. as filed with SEC (Form 4), a company from the Health Care sector. Between 23 October 2025 and 23 October 2026, 2 insiders published 13 filings.

On the market, 1 insider bought (12 purchases totalling €1.4M) while 1 insider sold (1 sale totalling €160k). Taken together, the purchases exceed the sales by €1.2M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Those buying include 1 major shareholder. At €428k, the purchase published on 3 August 2026 by ADAR1 Capital Management, LLC is the largest of the period (2.0% of market cap).

The clock since the last published purchase (3 August 2026) now reads 81 days. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction.

With 13 filings in twelve months, the company is quieter than the median of 24 filings across the 3,167 companies we follow on the same exchange. The full history, which starts in 2019, counts 17 purchases against 1 sale.

In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.